Edwards Lifesciences receives the BioAlps – Swiss Health Valley Industry Award at the BioAlps Networking Day 2026
Share this article
BioAlps – Swiss Health Valley presented its Industry Award to Edwards Lifesciences, the leading global structural heart innovation company, today at the BioAlps Networking Day 2026 at the Palais de Beaulieu in Lausanne. The award recognises Edwards’ long-standing commitment to patient-focused innovation in structural heart disease and its contribution to the Swiss Health Valley ecosystem.
More than 25 years in Western Switzerland
Edwards Lifesciences established its regional presence in Saint-Prex in 2000 and moved to Nyon in 2009. Nyon is the company’s headquarters for EMEA, Canada and Latin America, and a strategic and commercial hub for these regions. It is home to most of Edwards’ nearly 160 employees in Switzerland.
In Europe, Edwards manufactures in Limerick and Shannon, Ireland. A new plant is set to open next year in Moncada (Valencia), Spain.
Addressing an overlooked public health challenge
Cardiovascular disease is the leading cause of death in Europe. Within this growing burden, structural heart disease remains too often overlooked, under-recognised and underdiagnosed. This results in delays in diagnosis, referral and treatment, with significant consequences for patients and healthcare systems. In Europe alone, structural heart disease claims a life every ten minutes.
Edwards is the only global medtech company dedicated exclusively to structural heart disease. For more than 65 years, the company has pioneered breakthrough technologies that address unmet patient needs, transform care and improve outcomes for patients worldwide.
But the company’s contribution goes beyond technology. Edwards partners with trade associations, the scientific community and patient organisations to raise awareness of the disease, accelerate early detection, improve care pathways and enable timely access to care.
Rooted in the Swiss Health Valley’s innovation ecosystem
Switzerland has a long legacy in pharma and medtech, and the Swiss Health Valley carries that tradition forward. Edwards chose to settle in the Lake Geneva region to benefit from a strong network of nearby university hospitals and research institutions, as well as a highly skilled, multilingual and international talent pool. The region’s central position in Europe also helps the company coordinate a large and diverse territory from Nyon.
“For more than 65 years, Edwards has focused exclusively on structural heart disease, pioneering breakthrough technologies that transform care for patients with unmet needs. By combining innovation, world-class evidence and partnerships, we aim to deliver a triple benefit: better outcomes for patients, advanced care for physicians and greater efficiencies for healthcare systems. The BioAlps Industry Award is a powerful recognition of this commitment and the pioneering spirit that drives us every day,” said Annette Brüls, Corporate Vice President for EMEA, Canada and Latin America at Edwards Lifesciences.
About BioAlps – Swiss Health Valley
BioAlps is the life sciences cluster of Western Switzerland. As one of the region’s four sectoral platforms, it promotes Western Switzerland as a centre of excellence in life sciences under the Swiss Health Valley banner. It also supports knowledge transfer and innovation by connecting researchers, entrepreneurs, investors and industry. In 2026, the BioAlps Association, and therefore the Swiss Health Valley, celebrates its 25th anniversary, with over 600 participants at Palais Beaulieu Lausanne.
About Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, its employees are inspired by a patient-focused culture to deliver life-changing innovations to those who need them most.
Press contacts
- BioAlps: Sandra Ansanay-Alex, Communication & Event Manager, sandra.ansanay@bioalps.org | Tel. +41 78 264 84 14
- Edwards Lifesciences: Julie Tracol, Communications Director, julie_tracol@edwards.com | Tel. +41 75 431 74 95
📸 Picture: © BioAlps / Marc Bader. Magali Bischof, Secretary General of BioAlps; Antoine Geissbuhler, President of BioAlps – Swiss Health Valley and Dean of the Faculty of Medicine at the University of Geneva (UNIGE); and Annette Brüls (center), Corporate Vice President for EMEA, Canada and Latin America at Edwards Lifesciences, winner of the BioAlps – Swiss Health Valley Industry Award.